2018 SPEAKERS
William Adams, Partner, Knobbe Martens
Parastoo Azadi, Technical Director of Analytical Services and Senior Research Scientist, Complex Carbohydrate Research Center
Julio Baez, Former Head, Technology, Cipla BioTec
Christine Cannon, Global Lead, Sanofi
Ambrose Carrejo, Pharmaceutical Contracting Leader, Kaiser Permanente
Hubert Chen, Chief Medical and Scientific Officer, Pfenex Inc
Abdelhamid Cherfaoui, CEO, laboratory Frater -Razes
Matt Cooper, Business Development and Marketing Director, NIHR Clinical Research Network
Jennifer Day, Coordinator, Emerging Therapeutics Strategy Program, Kaiser Permanente
Yi Du, Director, Strategic Alliances, Huahai Pharma
Ronald Dudek, Director, Technology Development and Marketing, Lentigen Corporation
Nacer E. Hedroug, Former Director, QA Ops Injectable Vertical & Tech Transfer, Mylan Inc.
Michael Fairbanks, VP, Quality, Adello Biologics LLC
Gary Fanjiang, Executive Medical Director, Global Development, Biosimilars, Amgen Inc
Tiffany Fletcher, Executive Director of Government Affairs, Biosimilars, Sandoz
Peg Ford, President, Ovarian Cancer Alliance of San Diego
Vimal Gandhi, Director, Global Biosimilar Operations and Strategy, AstraZeneca
Jennifer Gao, Medical Officer, Oncology, FDA
Gerry Hoehn, Medical Director, Oncology, Teva Pharmaceuticals U.S.A.
Stacy Holdread, Staff Scientist, BD
Ruediger Jankowsky, Managing Director, Cinfa Biotech
Cheryl Koehn, President, Arthritis Consumer Experts
Chrys Kokino, Head Global Bioloigcs & Insulins - Commercial, Mylan Inc.
Dinesh Kundu, CEO & Co-Founder, QbD Biosciences
Dinesh Kundu, General Manager of Strategy, Business Development and Program Management, Intas Biopharmaceuticals Ltd.
Lawrence LaMotte, Principal Consultant, Advocacy Options
Brian Lehman, Strategic Consultant, Pharmacy Professional Affairs, Humana
Bruce Leicher, Senior Vice President, General Counsel, Momenta Pharmaceuticals Inc
Asif Mahmood, Safety strategy Disease Area Lead, Biosimilars, Pfizer
Brian Hosung Min, Vice President, Process Team, Samsung Bioepis
Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC
Maria Nishi, Director, Merck & Co
Jorge Santos da Silva, Partner, McKinsey & Company
Andrew Simpson, Scientific Director, Orygen Biotecnologia
Klemen Spaninger, Director of Project Management, Polpharma Biologics
Don Stewart, President and Chief Executive Officer, PlantForm
Vijay Tammara, Global Regulatory Head, Biosimilars, Wockhardt Limited
Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz
Chuck Velnoskey, Market Development Manager, BD Biosciences
Vladimir Vexler, EVP, Analytical and Translational Sciences, Coherus Biosciences
Anna Rose Welch, Executive Editor, Biosimilar Development
Chad Woods, Head of Patient Access, Sandoz